Raw Materials, Excipients and APIs

Pharmaceutical raw materials include active pharmaceutical ingredients (APIs) and inactive ingredients or excipients, which are pharmacologically active APIs that produce the desired pharmacological effect, while excipients are pharmacologically inactive substances that are often used as carriers of APIs in drugs.

 

Pharmaceutical Ingredients

Pharmaceutical raw materials include active pharmaceutical ingredients (APIs) and inactive ingredients or excipients, which are pharmacologically active APIs that 4A molecular sieves, while excipients are pharmacologically inactive substances that are often used as carriers of APIs in drugs.

 

 

Excipients

Excipients provide bulk to the formulation, facilitate absorption of the drug, provide stability and prevent drug denaturation. Pharmaceutical excipients are cost-effective, stable, easy to handle and inert in nature. Excipients are used in a variety of pharmaceutical products such as capsules, tablets, oral liquids, inhalers, implants, and injectables.

 

According to the ASD report, the global pharmaceutical excipients market is driven by the increasing demand for oral drugs. Factors such as improved patient compliance and ease of consumption are forcing drug manufacturers to develop oral solid dosage form products with very specific characteristics. The introduction of functional excipients has significantly enhanced the ability of drug formulators to develop poorly soluble API drugs or in some cases develop extended release dosage forms of existing drugs, thereby extending the shelf life and revenue of existing products.

 

North America holds the largest share of the pharmaceutical excipients market owing to the growing demand for pharmaceutical and biopharmaceutical drugs and the presence of a large number of excipients manufacturers in the region. Europe holds the second largest share, followed by Asia Pacific and Rest of the World. Asia Pacific is the fastest growing region, with emerging countries such as China and India emerging as major players due to low labor costs, increased outsourcing of inorganic and organic chemical manufacturing, and increased government spending on healthcare.

 

Active Pharmaceutical Ingredients

The global active pharmaceutical ingredients market continues to grow. Patent expiration of major drugs, government initiatives, regional penetration and increasing aging population are some of the factors driving the growth of the market. stringent validation and safety guidelines prescribed by WHO and fragmented market are the factors hindering the growth of API market.

 

The generic/non-branded segment of the industry has the largest market share during the forecast period due to rising healthcare costs, government focus on generic drugs due to reduction in healthcare costs, and declining global drug pipeline. Asia Pacific is expected to have the highest market share during the forecast period due to low operating costs and high investment in medical research. Moreover, high cost of skilled labor and energy are the most important factors forcing the European market to shift its base to developing countries such as India and China.

 

Hebei ATUN Trading Co., Ltd. dedicated to the development, production and marketing of chemicals which is specialized in Pharmaceutical Intermediates. We are well prepared for your any questions.